Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer
Dong Wang(Binzhou Medical University), Hailing Cheng(Dalian Medical University), Jean J. Zhao(Harvard University), Nan Jiang(Nanfang Hospital), Min Wang(Central South University), Yuan Zhang(Nantong University), Xiaoqing Wang(Roche (China)), Pixu Liu(Dalian Medical University), Xing Bian(Dalian Medical University), Thomas M. Roberts(Dana-Farber Cancer Institute)
Cited by 86
Related Papers
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
|Cell Death and Differentiation|2019|582